Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Fill out both forms, then either email or fax them to us at the contact above.
Provider? Stay in the know
Get the newest information from the Immunization Program right in your inbox!
Sign upCOVID-19 Vaccine Return Guidance Unopened vaccines should be returned when: The manufacturer expiration date has passed. The vaccines are no longer viable due to out-of-range temperatures. The vaccine has passed its beyond-use-date (BUD). When returning COVID-19 vaccines that have passed their beyond-use-date, remember to select Other as the return reason and include “Past...
Tips for Managing Short-Dated COVID-19 Vaccine Inventory COVID-19 vaccine shipped by McKesson in the following months will be short-dated, meaning the manufacturer expiration dates will be shorter than usual. McKesson will continue distributing COVID-19 doses until the vaccines are within 30 days of expiry. Here are...
Protect Your Patients from Flu, COVID-19, and RSV There are currently high rates of respiratory illness nationwide, including flu, COVID-19, and RSV. Continue to recommend immunization to prevent severe illness and hospitalization. Below, review eligibility recommendations from the CDC and stay updated on flu products available...
Reminder for Bridge Access Providers Only adults 18 and over who are uninsured or underinsured are eligible to receive a COVID-19 vaccine under the Bridge Access Program (BAP). Screening an individual for eligibility before giving a BAP COVID-19 dose is a requirement outlined in the provider agreement. Uninsured:...
COVID-19 Vaccine Returns Unopened vaccines should be returned when: The manufacturer expiration date has passed. The vaccines are no longer viable due to out-of-range temperatures. The vaccine has passed its beyond-use-date (BUD). When returning COVID-19 vaccines that have passed their beyond-use-date,remember to select Other as the return reason and include...
New Refrigerated Pfizer 12+ COVID-19 Vaccine A new presentation of Comirnity (Pfizer COVID-19 vaccine for 12+ year olds) (NDC 00069-2377-10) is now available to order. The new presentation: is a carton of 10 prefilled syringes. is a refrigerated formulation that must be stored between 2°C and 8°C (36°F and 46°F). Do not...
Deauthorized COVID-19 Products As a reminder, only the approved 2023 - 2024 COVID-19 products listed below may be administered at this time: Authorized 2023 - 2024 ProductsFormulation: Monovalent XBB.1.5 Pfizer 12+: NDC 00069-2362-10 Pfizer 5-11: NDC 59267-4331-02 Pfizer 6mo-4yrs: NDC 59267-4315-02 Moderna 12+: NDC 8077-0102-95 Moderna 6mo-11yrs: NDC 8077-0287-92 Novavax 12+: NDC 80631-0105-02 Previously...
Nirsevimab (Beyfortus) and COVID-19 Updates Nirsevimab Due to high demand and limited supply cited by the CDC, nirsevimab (Beyfortus) ordering through VFC has been put on hold as of October 17, 2023. The CDC is working with Sanofi to secure a supply of this immunization within the...
COVID-19 Vaccine Commercialization Tuesday, September 12, 2023, marked the beginning of COVID-19 commercialization. Here are some important changes to be aware of in this new period of COVID-19 vaccination: The Department of Public Health’s COVID-19 program has formally ended. Bivalent COVID-19 vaccines are no longer authorized for...
COVID-19 Program Ends Today Today, Tuesday, September 12, 2023, marks the end of PDPH's COVID-19 program and the beginning of commercialization. Bivalent COVID-19 vaccines are no longer be authorized for use. Any remaining products in your inventory must be immediately discarded. Use of unauthorized product to vaccinate patients is not...
